HEPATOLOGY

Scope & Guideline

Connecting experts to foster collaboration in hepatology.

Introduction

Immerse yourself in the scholarly insights of HEPATOLOGY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0270-9139
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1981 to 2024
AbbreviationHEPATOLOGY / Hepatology
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal 'Hepatology' focuses on advancing the understanding, prevention, diagnosis, and treatment of liver diseases through rigorous research and clinical studies. Its scope encompasses a broad range of topics related to hepatology, including but not limited to viral hepatitis, liver cancer, fatty liver disease, and liver transplantation. The journal aims to disseminate high-quality research findings that can influence clinical practice and improve patient outcomes.
  1. Viral Hepatitis Research:
    This area includes studies on the epidemiology, pathogenesis, and treatment of hepatitis viruses (A, B, C, D, and E), focusing on novel antiviral therapies and their clinical implications.
  2. Liver Cancer and Oncology:
    Research on hepatocellular carcinoma (HCC) and cholangiocarcinoma, including mechanisms of tumorigenesis, therapeutic strategies, and outcomes of various treatment modalities.
  3. Liver Disease Mechanisms:
    Investigations into the cellular and molecular mechanisms underlying liver diseases such as non-alcoholic fatty liver disease (NAFLD), alcohol-related liver disease, and autoimmune liver conditions.
  4. Transplantation and Regenerative Medicine:
    Studies focused on liver transplantation, including donor selection, post-transplant outcomes, and the role of stem cells and organoids in liver regeneration.
  5. Clinical Guidelines and Practice:
    The journal publishes consensus guidelines and practice recommendations to improve the management of liver diseases, emphasizing evidence-based approaches.
  6. Innovative Diagnostic Techniques:
    Research utilizing advanced diagnostic modalities such as imaging techniques, serum biomarkers, and non-invasive fibrosis assessment methods for better disease characterization.
  7. Public Health and Epidemiology:
    Articles addressing the epidemiological aspects of liver diseases, including the impact of lifestyle factors, health disparities, and public health initiatives for prevention and management.
Recent publications in 'Hepatology' indicate several trending and emerging themes that reflect the evolving landscape of liver disease research. These themes highlight innovative approaches, novel therapeutic strategies, and a comprehensive understanding of liver disease mechanisms.
  1. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD):
    Research on MAFLD is gaining momentum, emphasizing the need for updated diagnostic criteria and treatment strategies that address the metabolic aspects of liver disease.
  2. Artificial Intelligence in Hepatology:
    The integration of AI and machine learning techniques for diagnosing liver diseases, predicting outcomes, and personalizing treatment regimens is becoming increasingly prominent.
  3. Personalized Medicine Approaches:
    Emerging studies focusing on tailoring therapies based on individual patient characteristics, genetic profiles, and specific disease phenotypes are trending.
  4. Non-Invasive Diagnostic Modalities:
    There is a marked increase in research on non-invasive techniques for diagnosing liver conditions, including transient elastography, MRI-based assessments, and blood-based biomarkers.
  5. Gut-Liver Axis Research:
    The exploration of the gut microbiome's role in liver disease pathogenesis and treatment responses is an emerging area of interest, linking gastrointestinal health to liver outcomes.
  6. Longitudinal Studies and Real-World Evidence:
    There is a growing trend towards longitudinal studies that provide real-world evidence on the effectiveness of therapies and the natural history of liver diseases.
  7. Public Health Interventions:
    Research focusing on the impact of public health policies and community-based interventions for liver disease prevention and management is gaining traction.

Declining or Waning

While 'Hepatology' has consistently covered various aspects of liver diseases, certain research areas appear to be declining in prominence based on recent publications. This may reflect shifting priorities within the field, advancements in understanding, or the saturation of existing knowledge in those areas.
  1. Traditional Liver Biopsy Techniques:
    There has been a noticeable decline in studies focused on traditional liver biopsy methods as non-invasive techniques for assessing liver fibrosis gain popularity and acceptance.
  2. Alcohol-Induced Liver Disease:
    Although still an important topic, research specifically focused on classic alcohol-induced liver disease may be waning as attention shifts towards broader metabolic dysfunction-associated liver diseases (MASH) and their multifactorial causes.
  3. Basic Science Studies:
    The journal has seen fewer purely basic science studies as there is a growing emphasis on translational research that can directly impact clinical practice and patient care.
  4. Viral Hepatitis Monotherapy Studies:
    Research focusing solely on monotherapy for hepatitis treatments is declining in favor of combination therapies that target multiple pathways and improve treatment efficacy.
  5. Outdated Diagnostic Biomarkers:
    Research on older biomarkers for liver disease diagnosis is decreasing as newer, more effective biomarkers are developed and validated.

Similar Journals

Clinics in Liver Disease

Connecting researchers and clinicians for liver health advancements.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1089-3261Frequency: 4 issues/year

Clinics in Liver Disease is an esteemed peer-reviewed journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of hepatology. Established in 1997 and covering a broad range of topics within liver disease research, this journal serves as a vital resource for researchers, clinicians, and students engaged in the study of liver health and diseases. With a commendable impact factor placing it within the Q2 category in Hepatology and ranking #32 out of 82 in the Scopus classifications, it consistently disseminates high-quality research and clinical insights. The journal’s commitment to promoting understanding and management of liver diseases is reflected in its rigorous editorial standards and comprehensive review processes. Although not an open-access publication, Clinics in Liver Disease offers subscription options that ensure accessibility to up-to-date research and reviews critical for both academic and clinical success.

World Journal of Hepatology

Pioneering insights into hepatology for a healthier world.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1948-5182Frequency: 12 issues/year

World Journal of Hepatology is a premier academic journal dedicated to advancing the field of hepatology. Published by BAISHIDENG PUBLISHING GROUP INC, this journal serves as a crucial platform for disseminating innovative research findings and critical reviews from around the globe. With its ISSN 1948-5182 and E-ISSN 1948-5182, the journal has established a notable presence since its inception in 2009, covering a wide range of topics relevant to liver diseases, including but not limited to hepatitis, liver cancer, and metabolic liver disorders. Currently ranked 41/82 in the field of hepatology by Scopus, representing the 50th percentile, it has achieved a Q3 quartile ranking in the 2023 category, underscoring its growing influence in the medical community. With a commitment to open access for its readership, the World Journal of Hepatology enriches the global discourse on liver health and disease management, making it an essential resource for researchers, clinicians, and students alike.

Saudi Journal of Gastroenterology

Elevating standards in gastrointestinal research and practice.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-3767Frequency: 6 issues/year

The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.

JGH Open

Connecting Researchers, Transforming Outcomes
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

Korean Journal of Gastroenterology

Elevating Understanding of Gastrointestinal Disorders
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

International Journal of Hepatology

Advancing liver health through open-access research.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

Clinical and Molecular Hepatology

Transforming the landscape of hepatology with cutting-edge studies.
Publisher: KOREAN ASSOC STUDY LIVERISSN: 2287-2728Frequency: 4 issues/year

Clinical and Molecular Hepatology, published by the Korean Association for the Study of Liver, stands at the forefront of hepatology, offering a significant platform for research and innovation in liver diseases. Established in 1995 as an open access journal, it aims to disseminate high-quality research that spans the fields of hepatology, molecular biology, and medicine. With an impressive impact factor ranking it in the Q1 category for 2023 in both Hepatology and Molecular Biology, the journal facilitates a rich exchange of knowledge among professionals, researchers, and students globally. With its dedicated coverage from 2012 to 2024 and exceptional Scopus rankings placing it within the top 10% of journals in its field, Clinical and Molecular Hepatology is an indispensable resource for advancing the understanding and treatment of liver conditions. Located in Seoul, South Korea, the journal emphasizes rigorous peer review and is committed to enhancing clinical practice and molecular research, making it an ideal venue for groundbreaking studies in liver health.

DIGESTIVE AND LIVER DISEASE

Unlocking the complexities of digestive and liver diseases.
Publisher: ELSEVIER SCIENCE INCISSN: 1590-8658Frequency: 12 issues/year

DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.

Hepatology International

Exploring the frontiers of liver disease understanding.
Publisher: SPRINGERISSN: 1936-0533Frequency: 4 issues/year

Hepatology International is a premier academic journal dedicated to advancing the field of liver research and hepatology. Published by SPRINGER, this journal boasts a prestigious Q1 ranking in Hepatology as of 2023, underscoring its commitment to high-quality research dissemination. The journal’s scope encompasses a wide range of topics related to liver disease, including clinical, translational, and basic science studies. With its impact factor reflecting its relevance and influence in the field, Hepatology International serves as an essential resource for researchers, clinicians, and students aiming to keep abreast of the latest developments and breakthroughs. Though traditionally a subscription-based journal, it offers a vast array of insightful articles that contribute significantly to our understanding of hepatological conditions. The journal continues its trajectory of growth since its inception in 2008, anticipating a convergence of knowledge and innovation through to 2024. Located in the heart of New York City, this journal not only represents a crucial platform for global hepatology research but also fosters a collaborative community of experts dedicated to improving liver health worldwide.

Hepatology Communications

Advancing liver health through innovative research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 12 issues/year

Hepatology Communications, published by Lippincott Williams & Wilkins, serves as a pioneering platform in the field of hepatology, dedicated to advancing the understanding of liver diseases and treatments. Since its inception in 2017, this open access journal has rapidly gained recognition, achieving an impressive Q1 ranking in Hepatology as of 2023, and appealing to a diverse audience of researchers, clinicians, and students alike. With its focus on high-quality research and clinical studies, the journal aims to facilitate impactful discussions and disseminate vital findings that address the challenges faced in liver health. Operating out of the United States, and accessible globally, Hepatology Communications is committed to fostering a collaborative research environment and enhancing the visibility of scholarly work in hepatology, ultimately driving forward innovations in patient care and treatment strategies.